Skip to content

SCHEDULE 13G/AAccepted May 8, 11:33 AM ET

Rein Therapeutics, Inc. SCHEDULE 13G/A

BIOS Fund I, LP

sec.gov(opens the filing on sec.gov)

Accepted (ET)

11:33 AM

May 8, 2026

Filed

May 8, 2026

Documents

1

Size

101.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.